FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA to Review Agios Pyrukynd sNDA

FDA says it will review an Agios sNDA for a new Pyrukynd indication and sets a 9/7 PDUFA action date.

latest-news-card-1
Human Drugs

FDA Puts Marengos Invikafusp on Fast Track

FDA grants fast track designation to Marengos invikafusp T cell activator for some colorectal cancers.

Medical Devices

FDA Clears ZuriMED Rotator Cuff Reinforcer

FDA clears a ZuriMED Technologies 510(k) for the FiberLocker System for rotator cuff repair reinforcement.

latest-news-card-1
Federal Register

Priority Voucher Awarded to Neurocrine Biosciences

Federal Register notice: FDA announces it has issued a priority review voucher to Neurocrine Biosciences because its 12/13 NDA approval for Crenessity...

latest-news-card-1
Medical Devices

Fresenius Recalls Ivenix Infusion Pumps

Fresenius Kabi recalls its Ivenix Infusion System due to potential pneumatic valve failures that may cause the pump to stop an active infusion.

latest-news-card-1
Medical Devices

J&J Pauses Varipulse Rollout

Johnson & Johnson says it is pausing the limited U.S. rollout of its new Varipulse ablation technology while it investigates the root cause of four pa...

latest-news-card-1
Medical Devices

Breakthrough Status for Heart Failure Device

FDA grants Alleviant Medical a breakthrough designation for its no-implant atrial shunt technology for treating heart failure with reduced ejection fr...

latest-news-card-1
Human Drugs

Create Labeling-only NDA: Report

Three RebootRx executives call on FDA to create a labeling-only 505(b)(2) NDA pathway to allow non-manufacturers to seek approval for repurposed gener...

latest-news-card-1
Federal Register

Draft Guide on Optical Imaging Drugs

Federal Register notice: FDA makes available a draft guidance entitled Developing Drugs for Optical Imaging.

latest-news-card-1
Federal Register

Guide on Developing Obesity Drugs

Federal Register notice: FDA makes available a draft guidance entitled Obesity and Overweight: Developing Drugs and Biological Products for Weight Red...